Divi's Laboratories Share Price, Stock Analysis & Company Profile

Divi's Laboratories Limited is one of India’s leading pharmaceutical companies specialising in active pharmaceutical ingredients (APIs), intermediates, and custom synthesis. Known for its strong global presence and high-margin business model, the company has established itself as a key supplier to major global pharma innovators. This page serves as a comprehensive hub for investors seeking an in-depth Divi's Laboratories stock analysis, providing all the essential tools to track the Divi's Laboratories share price and evaluate its long-term growth potential.

About Divi's Laboratories

Founded in 1990 by Dr. Murali K. Divi, the company is headquartered in Hyderabad, India. Over the decades, it has built a reputation for high-quality manufacturing, regulatory compliance, and strong relationships with global pharmaceutical companies.

Divi's Laboratories operates primarily as a pure-play API and custom synthesis company, focusing on large-scale manufacturing with cost leadership. It has multiple manufacturing facilities in India, all compliant with stringent international regulatory standards such as USFDA and EU GMP.

Divi's Laboratories Business Model

The business model of Divi's Laboratories is built on the pillars of "Custom Synthesis, Generic APIs, and Operational Excellence." It operates through a highly specialised and scalable portfolio:

Custom Synthesis (CRAMS): This segment involves contract manufacturing for global innovator pharma companies, contributing significantly to revenues and margins.
Generic APIs: Manufacturing and supplying high-volume generic APIs for regulated markets such as the US and Europe.
Nutraceutical Ingredients: Production of vitamins and nutraceutical products, including carotenoids, catering to global health and wellness markets.
Intermediates: Supplying advanced intermediates used in pharmaceutical manufacturing.
Export-Oriented Model: A large portion of revenue is derived from exports, making the company a key player in the global pharma supply chain.

Divi's Laboratories IPO and Listing Details

The journey of Divi's Laboratories on the Indian stock exchanges marks it as one of the consistent performers in the pharma sector. These historical milestones remain important reference points for long-term investors.

IPO Listing Year: 2003
IPO Price: Rs 140 per share
Listing Price: The stock debuted strongly, listing at a premium to its issue price.
Listing Gain: Approximately 30%+ on listing (market-dependent).
Face Value: Rs 2 per share
ISIN: INE361B01024
Listing Exchanges: BSE and NSE
BSE Scrip Code: 532488
NSE Symbol: DIVISLAB

Divi's Laboratories Corporate Action History

Divi's Laboratories has maintained a consistent track record of rewarding shareholders through dividends and occasional corporate actions, reflecting strong cash generation and profitability.

Stock Split History

The company has undertaken stock splits to improve liquidity and make shares more accessible to retail investors.

2010: Stock Split from a Face Value of Rs 10 to Rs 2
Ex-Date: 08 September 2010

Bonus Share History

Divi's Laboratories has also issued bonus shares to enhance shareholder value.

2015: 1:1 Bonus Issue (1 bonus share for every 1 share held)
Ex-Date: 16 July 2015

Investor Note: Divi's Laboratories is known more for consistent dividends and strong earnings growth rather than frequent corporate actions, making it a preferred choice for long-term investors seeking stability.

Investor Resources Available on This Page

We believe in empowering retail investors with professional-grade data. On this page, you can access a wealth of information to conduct your own Divi's Laboratories stock analysis through the following sections:

Price Chart: Analyse historical price movements and trends to understand the Divi's Laboratories share price trajectory.
Company Ratios: Access key metrics like PE ratio, ROE, ROCE, and EBITDA margins to evaluate valuation.
Quarterly Results & Balance Sheet: Review the company’s latest earnings, export performance, and profitability metrics.
Cash Flow & Annual Reports: Deep dive into the financial health and operational efficiency through official documents and cash flow statements.
Shareholding Pattern: Check the latest ownership data, including promoter holdings and institutional participation (FII/DII).
Pros & Cons: A simplified summary of the company’s strengths, such as strong global client relationships, and potential risks, such as dependence on a few key molecules.

Frequently Asked Questions

Q1. What is the Divi's Laboratories share price today?
The share price displayed at the top of this page reflects the latest trading value on the NSE and BSE. Please note that the price chart data is delayed by 15 minutes.

Q2. What does Divi's Laboratories do?
Divi's Laboratories manufactures active pharmaceutical ingredients (APIs), intermediates, and provides custom synthesis services to global pharmaceutical companies.

Q3. What was the IPO price of Divi's Laboratories?
The Divi's Laboratories IPO was issued at a price of Rs 140 per share in 2003.

Q4. Has Divi's Laboratories issued bonus shares?
Yes, the company issued bonus shares in a 1:1 ratio in July 2015.

Q5. Where are Divi's Laboratories shares listed?
The shares are listed and traded on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

Q6. What is the current face value of Divi's Laboratories shares?
Following the stock split in 2010, the face value of each equity share is Rs 2.

Q7. How can I access the Divi's Laboratories Annual Report?
You can download the latest Annual Report and investor presentations from the "Reports" or "Documents" section available on this page.